Presentations at meetings

Publications
Papers in preparation
Presentations at meetings

Redlinger R., Poggio, K. Muñoz, A. Mor, G. (2000) The role of the Fas/FasL system in the estrogen-induced thymic alteration. . American Society for Reproductive Immunology. Jacksonville, Florida, Abstract #2

Aschkenazi, SO, Verwer, KMA, Foellmer, H. Mor, G. (2000) Differential effects of T-Helper-1 and T Helper-2 type cytokines on normal human trophoblast expression of Fas and Fas ligand: Possible role in implantation. American Society for Reproductive Immunology. Jacksonville, Florida, Abstract #25

Muñoz, A.A., Redlinger, R., Kohen, F., Mor, G. (2000) differential expression of estrogen receptors a and b in the thymus. American Society for Reproductive Immunology. Jacksonville, Florida, Abstract #27

Gil Mor, Joon Song, Wendi Brown, Frederick Naftolin Estrogen and the FAS/FAS Ligand System in Breast Cancer Cells: Functional Differences between Estradiol and Tamoxifen. Blue Ribbon presentation. SGI Chicago IL, Abstract # 8

Thomas Rutherford, Eva Sapi, Wendi Brown, Karlijn Verwer, Amanda Munoz, Gil Mor (2000) Fas and Fas Ligand Expression in Normal and Pathologic Ovarian Tissue. SGI Chicago IL, Abstract # 9

Wendi Brown, Gil Mor, Thomas Rutherford, Karrie Tartaro, Eva Sapi (2000) Fas Ligand Expression Is Regulated by Estrogens in Normal and Neoplastic Ovarian Epithelia. SGI Chicago IL, Abstract # 41

Joon Song, Eva Sapi, Jon Nilsen, Hyun C Lim, Frederick Naftolin, Gil Mor (2000) The Role of the Fas/Fas Ligand System in Breast Tissue: Normal Differentiation Versus Breast Cancer. . SGI Chicago IL, Abstract # 531

M Sbracia, R Poverini, A Rossi, M DeFelici, F Scarpellini, C Aragona, G Micara, G Mor. (2000) FAS-Receptor/FAS-Ligand System Regulates with an Autocrine/Paracrine Mechanisms the Apoptosis in Human Pre-Embryos. SGI Chicago IL, Abstract # 605

Brown, WD., Sapi, E., Verwer, KMA., Mor, G. (1999) Fas Ligand regulation in an ovarian organ culture system: Implications for ovarian cancer. American Society for Reproductive Immunology. Cooperstown, NJ ; Abstract # P-9

Verwer, KMA., Brown, WD., Foellmer, HG., Mor, G. (1999) Macrophage derived growth factors modulate Fas Ligand expression in cultured trophoblast cells: A role in implantation. American Society for Reproductive Immunology. Cooperstown, NJ ; Abstract # P-10

Mor, G., Brown s., Rosen, R., Song, J., Brown WB., Naftolin, F. (1999) Regulation of Fas Ligand expression in breast cancer cells by estrogen: Functional differences between estradiol and tamoxifen. American Society for Reproductive Immunology. Cooperstown, NJ ; Abstract # O-9

Zaltsman, Y., Mor, G., Ben-Hur, H., Gayer, N., Nevo, N., Kohen, F. (1999) Hormonal Regulation of Fas Ligand in the rat prostate: Implications for prostate cancer. Endocrine Society San Diego CA.

Nilsen, J., Mor, G., Naftolin, F. (1999) Raloxifene is an estrogen agonist, inducing neurite outgrowth in PC12 cells. Society for Gynecologic Investigation, Atlanta, Georgia. Abstract # 723

Garcia-Velasco, J., Arici, A., Naftolin, F., Zreik, T., Mor, G. (1999) Macrophage-Derived growth factors modulate Fas ligand expression in endometrial stromal cells: a role in endoemtriosis. Society for Gynecologic Investigation, Atlanta, Georgia. Abstract #

Hsu, CD., Gutierrez, LS., Meaddough, E., Basheera, H., Lu, LC., Copel, JA., Harirah, H., Mor, G. (1999). Expression of Fas ligand by preeclamptic placenta. Society for Maternal-Fetal Medicine. San Francisco. Abstract #

Mor, G, Gutierrez L.S,, Eliza M., Kahyaogili, F., Arici, A. (1998). Induction of apoptosis mediated by the Fas-fas ligand system in human placental trophoblast and gestational trophoblastic disease. Society for Gynecologic Investigation. 45 th Annual Meeting. Atlanta, Georgia. Abstract # 55.

Senturk, L.M., Mor, G., Gutierrez, L.M., Zeyneloglu, H.B., Bahtiyar, M.O., Arici, A. (1997). Monocyte Chemoattractant Protein-1 expression in human corpus luteum. American Society for Reproductive Medicine. 53Rd Annual Meeting. Cincinnati, Ohio.

Diano, S., Mor, G., Horvath, T., Register, T., Adams, M., Naftolin, F. (1997). Estrogen formation by coronary arteries? .The presence of immunoreactive-Aromatase (irARO) and estrogen receptors (irER) in monkey and human coronary arteries. 8th Annual Meeting , NAM, Boston, MA.

Ben-Hur, H., Mor, G., Blickstein, I., Likhman, I., Amir-Zaltsman, Y., Sharp, A., Insler, V., Globerson, A., & Kohen, F. (1993). Expression of estrogen receptors [ER] in human monocytes in relation to menopause and hormone replacement therapy. In: 23rd Annual Meeting of the Israel Immunological Society, #43. Ben-Gurion University, Ber-Sheba, Israel.

Mor, G., Amir-Zaltsman, Y., Ben-Hur, H., Sharp, A., & Kohen, F. (1993). Expression of Estrogen receptors in Human Peripheral mononuclear cells is associated mainly with monocytes. In: 23rd Annual Meeting of the Israel Immunological Society, #54 . Ben-Gurion University, Ber-Sheba, Israel.

Mor, G., Amir-Zaltsman, Y., Bernard, G., & Kohen, F. (1993). Evidence for the presence of estrogen receptors in monocytes. In: 75th Annual Meeting of the Endocrine Society. Las Vegas, Nevada.

Ben-Hur, H., Mor, G., Blickstein, I., Dagani, R., Insler, V., & Kohen, F. (1991-1992). Immunofluorescence studies of estrogen and progesterone receptor distribiution in the human endometrium using anti-idiotypic antibodies . In: Annual Meeting of the Israel Endocrine Society. Jerusalem, Israel.

Mor, G., Kukulansky, T., Kohen, F., & Globerson, A. (1991). Patterns of estrogen Receptor expression on thymocytesfrom young and old mice. In: Israel Immunological Society , 21st Annual Meeting. Rehovot, Israel.

Amir-Zaltsman, Y., Mor, G., Barnard, G., Gayer, B., Lichter, S., & Kohen, F. (1991). Anti-idiotypic antibodies against anti-estradiol: Preliminary characterization and probes for the study of the estrogen receptor. In: Endocrine Society, Annual Meeting . Washington.

Amir-Zaltsman, Y., Levi, L., Mor, G., Ben-Aroya, N., Koch, Y., & Kohen, F. (1990-1991). Anti-idiotypic antibodies against anti-buserelin: Probes for the study of the GnRH receptor. In: Annual Meeting of the Israel Endocrine Society. Tel-Aviv, Israel.

Mor, G., Fajer, A., Barnard, B., Gayer, B., Lichter, S., & Kohen, F. (1990-1991). Monoclonal anti-idiotypic antibodies against anti-estradiol: use in the direct localization of estrogen receptor. In: Annual Meeting of the Israel Endocrine Society. Tel-Aviv, Israel.

Mor, G., Fajer, A., Barnard, G., & Kohen, F. (1990). Use of fluorescent labeled monoclonal anti-idiotypic steroidal antibodies in the direct localization of cytoplasmatic and nuclear estrogen receptor. In: The Endocrine Society ,72 Annual Meeting. Atlanta, Georgia.

Fajer, A., Barnard, G., Mor, G., & Kohen, F. (1989). Use of anti-idiotypic antibodies in the localization by immunofluorescence of parenterally administered monoclonal antibodies to estradiol in female rars. In: The Endocrine Society 71st Annual Meeting. Washington.

Mor, G., Amir-ZAltsman, Y., Bernard, G., Gayer, B., Lichter, S., Osher, S., & Kohen, F. (1992). Characterization of an anti-idiotypic antibody that recognizes estrogen receptors. In: 74th Annual Meeting of the Endocrine Society, (pp. #731). San Antonio,Texas.

Mor, G., Saphier, D., & Feldman, S. (1985). Effects of corticosterone (CS) upon paraventricular nucleus (PVN) multi-unit activity (MUA) following neurogenic stimulation. In: Annual Meeting of the Israel Endocrine Society, Abstr. # 76. Tel Aviv, Israel.

Naftolin, F., Mor, G., Luquin, S., Fager, A., Lewis, C., Feefe, D., Kohen, F., & Garcia-Segura, L. (1993). Synaptic Plasticity in the hypothalamus arcuate nucleus during the estrus cycle is induced by estrogen and limited to the periventricular zone of reaction. In: 74th Annual Meeting of the Endocrine Society, #1804 . Las Vegas, Nevada.

Saphier, D., Abramsky, O., Mor, G., & Ovadia, H. (1986). A physiological correlate of an immune response. In: 6th International Congress of Immunology. Toronto, Canada.

Saphier, D., Mor, G., & Feldman, S. (1986). Effects of corticosterone on paraventricular nucleus multiple unit activity responses to neural stimuli in concious animals. In: 30th International Congress of Physiological Sciences. Vancouver, Canada.